Literature DB >> 11956070

c-myc-induced apoptosis in polycystic kidney disease is independent of FasL/Fas interaction.

Martin Couillard1, Richard Guillaume, Nozomu Tanji, Vivette D'Agati, Marie Trudel.   

Abstract

Apoptosis is a critical early cellular event in the development of polycystic kidney disease (PKD) in humans and mice. In the SBM transgenic model of PKD, both apoptosis and proliferation are c-myc driven and are independent of p53 and Bcl-2 pathways. On the basis of recent evidence implicating the FasL/Fas pathway in c-myc-induced apoptosis, we investigated the potential interaction of these pathways in vivo. We first evaluated the expression of FasL in renal tissues of SBM mice. This analysis showed that the level of FasL expression was elevated 3-4-fold in the SBM kidneys, indicating a potential autocrine suicidal mechanism. We next crossed the SBM mice with gld mice mutated in FasL. The progenies had comparable renal epithelial apoptotic and proliferation rates and a cystic phenotype in all SBM genotypes irrespective of the FasL genotype. Our study proves that c-myc-induced apoptosis can be independent of the FasL/Fas pathway in vivo and implicates the existence of a novel c-myc-driven apoptotic pathway.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11956070

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

Review 1.  Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease.

Authors:  Peter C Harris; Vicente E Torres
Journal:  J Clin Invest       Date:  2014-06-02       Impact factor: 14.808

2.  Overexpression of PKD1 causes polycystic kidney disease.

Authors:  Caroline Thivierge; Almira Kurbegovic; Martin Couillard; Richard Guillaume; Olivier Coté; Marie Trudel
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

3.  MafB is essential for renal development and F4/80 expression in macrophages.

Authors:  Takashi Moriguchi; Michito Hamada; Naoki Morito; Tsumoru Terunuma; Kazuteru Hasegawa; Chuan Zhang; Tomomasa Yokomizo; Ritsuko Esaki; Etsushi Kuroda; Keigyou Yoh; Takashi Kudo; Michio Nagata; David R Greaves; James Douglas Engel; Masayuki Yamamoto; Satoru Takahashi
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

4.  Pkd1 transgenic mice: adult model of polycystic kidney disease with extrarenal and renal phenotypes.

Authors:  Almira Kurbegovic; Olivier Côté; Martin Couillard; Christopher J Ward; Peter C Harris; Marie Trudel
Journal:  Hum Mol Genet       Date:  2010-01-06       Impact factor: 6.150

5.  Apoptosis and autophagy in polycystic kidney disease (PKD).

Authors:  Kristen L Nowak; Charles L Edelstein
Journal:  Cell Signal       Date:  2019-12-24       Impact factor: 4.315

6.  c-Myc is a regulator of the PKD1 gene and PC1-induced pathogenesis.

Authors:  Camila Parrot; Almira Kurbegovic; Guanhan Yao; Martin Couillard; Olivier Côté; Marie Trudel
Journal:  Hum Mol Genet       Date:  2019-03-01       Impact factor: 6.150

7.  Roles of telomeres and telomerase in age‑related renal diseases (Review).

Authors:  Haili Li; Boyuan Wang; Daoqun Li; Jinyuan Li; Ying Luo; Juhua Dan
Journal:  Mol Med Rep       Date:  2020-12-10       Impact factor: 2.952

8.  Parallel analysis of mRNA and microRNA microarray profiles to explore functional regulatory patterns in polycystic kidney disease: using PKD/Mhm rat model.

Authors:  Harsh Dweep; Carsten Sticht; Asawari Kharkar; Priyanka Pandey; Norbert Gretz
Journal:  PLoS One       Date:  2013-01-10       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.